Background
PsA, heterogenous, Psoriatic arthritis
PSORIATIC ARTHRITIS, INFLAMMATORY DISEASE
Psoriatic arthritis (PsA) is a heterogenous and chronic systemic inflammatory disease that can manifest in multiple domains [Guselkumab is a high-affinity, fully human, monoclonal antibody that targets the IL-23p19 subunit [Previous analyses have shown that C-reactive protein (CRP) and type 17 effector cytokine serum levels are elevated in patients with PsA and can be reduced by inhibiting the IL-23p19 subunit or the IL-12/23p40 subunit [